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independently of absorbed doses distribution, together with 
abnormal mitosis. The latter results indicate that bystander 
effects could also be involved. However, at this stage, we 
may assume that they do not fully counterbalance the lack of 
efficacy due to heterogeneous distribution of anti-CEA 212Pb-
mAbs, possibly because lesions are not as complex as those 
produced by high LET radiation.  
Conclusions: Our results showed in vitro and in vivo that, 
besides the strong direct effect of 212Pb-labeled mAbs in 
killing tumour cells, bystander effects have also to be 
considered.  
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Radiotherapy is an important treatment modality for millions 
of patients with cancer worldwide. Current treatment 
decisions do not take into account individual patients’ or 
cohorts of patients’ sensitivities to this treatment modality. 
As such, patients treated with radiation therapy experience a 
large variation in normal tissue toxicity that results in dose-
limiting acute and irreversible progressive side effects. 
Important examples of these adverse effects include 
mucositis, pneumonitis, and cognitive damage, respectively 
representing acute, intermediate, and late effects. 
Stratification of patients based on radiation sensitivities will 
allow delivery of suitable alternative treatments to high-risk 
patients and dose escalation to tumors in less sensitive 
patients. Current focus on radiation 
biomarkers/biodosimeters appears to be primarily to assess 
radiation doses after catastrophic accidental radiation 
exposure. Recent advances have brought together several 
cross-disciplinary areas such as biological assays, analytical 
platforms, and algorithms to rapidly assess dose to 
individuals. These technologies are at different maturation 
levels. This immense progress is also an opportunity to use 
them to predict heterogeneity of radiation sensitivities 
among cancer patients to improve radiation therapy outcome 
and their quality of life. This talk will emphasize the need 
for discovery, development, and validation of predictive 
biomarkers, provide some examples of biomarkers, and 
discuss the translational challenges involved in leveraging 
advances in radiation-specific biomarker research to 
radiotherapy, which for the foreseeable future likely to 
remain a cornerstone of cancer treatment.  
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Purpose: Range verification in proton therapy is highly 
desirable to fully exploit the advantageous properties of 
proton beams for tumor therapy. In this context, prompt 
gamma imaging (PGI) is of growing interest and different 
technical concepts for realization are currently under 
investigation. The feasibility of range shift detection with a 
slit camera has previously been shown for different targets 
irradiated with protons in pencil beam scanning mode [1-3]. 
In preparation of the clinical application of the slit camera 
within a patient study, we report on the first application of 
the slit camera to passively shaped proton beams.  
Materials / Methods: Targets with increasing complexity have 
been irradiated with passively shaped proton beams (double 
scattering mode). For artificial range shift induction, the 
energy of the protons was varied. Prompt gamma emission 
was monitored by means of a knife-edge shaped slit camera.  
Prompt gamma rays emitted during the irradiation are 
projected through a slit aperture onto a segmented detector. 
Thus, a one-dimensional depth distribution of detected 
prompt gamma rays is obtained.  
In double scattering mode, a high neutron induced 
background hampers direct range shift evaluation from these 
detected gamma distributions. In order to quantify this 
background, measurements have been repeated with a closed 
slit aperture of the camera. This facilitates a subtraction of 
the background from the measurements with open slit. 
Time resolved analysis of the measurements allows for a 
mapping of single prompt gamma profiles to different steps 
of the range modulator wheel, and, thus, to different iso-
energy layers. 
Results: Global range shifts of several millimeters in 
homogeneous as well as inhomogeneous targets were 
detected with the slit camera measurement during proton 
irradiation with passive field formation. Figure 1 shows the 
experimental setup with a head target (left) and detected 
prompt gamma profiles for different proton energies, i.e. 
different requested proton ranges (right). Separation of 
different prompt gamma profiles related to single steps of 
the range modulator wheel was possible. 
 
 
 
Figure 1: Left: Experimental setup of a prompt gamma slit 
camera measurement during irradiation of a head phantom 
with a passively shaped proton beam. Right: Measured 
prompt gamma depth profiles, normalized to the applied 
monitor units (MU) for different requested proton ranges, i.e. 
different proton energies. 
 
Conclusions: In preparation of the application of the slit 
camera to patient treatment, we investigated the 
detectability of range shifts in double scattering proton 
irradiation. Global range shifts of a few millimeters were 
detected from measurements with the slit camera. Time 
resolved analysis allows for separation of prompt gamma 
profiles correlated to protons of different iso-energy layers. 
This might provide additional information on potential 
sources of range deviations. 
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